These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12145002)

  • 1. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.
    Nestel P; Shige H; Pomeroy S; Cehun M; Abbey M; Raederstorff D
    Am J Clin Nutr; 2002 Aug; 76(2):326-30. PubMed ID: 12145002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
    Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
    Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
    Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects.
    Conquer JA; Holub BJ
    J Nutr; 1996 Dec; 126(12):3032-9. PubMed ID: 9001371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.
    Finnegan YE; Minihane AM; Leigh-Firbank EC; Kew S; Meijer GW; Muggli R; Calder PC; Williams CM
    Am J Clin Nutr; 2003 Apr; 77(4):783-95. PubMed ID: 12663273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.
    Grimsgaard S; Bønaa KH; Hansen JB; Myhre ES
    Am J Clin Nutr; 1998 Jul; 68(1):52-9. PubMed ID: 9665096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
    Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
    Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
    Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
    Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers.
    Dewailly E E; Blanchet C; Gingras S; Lemieux S; Sauvé L; Bergeron J; Holub BJ
    Am J Clin Nutr; 2001 Nov; 74(5):603-11. PubMed ID: 11684528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.
    Peet M; Brind J; Ramchand CN; Shah S; Vankar GK
    Schizophr Res; 2001 Apr; 49(3):243-51. PubMed ID: 11356585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
    Jacobson TA; Glickstein SB; Rowe JD; Soni PN
    J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ; Hammervold T; Rustan AC; Howe PR
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
    Castro IA; Monteiro VC; Barroso LP; Bertolami MC
    Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.